22 September 2011
SanBio, Inc., a leader in cell therapies for regenerative medicine, has announced the site initiation and opening of a Phase 1/2a clinical trial testing a novel cell therapy product, SB623, in patients suffering from disability resulting from ischemic ...
Posted in Cancer News Today, Cancer Research0 Comments
22 September 2011
According to a study published in a recent issue of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research, colorectal cancer screening rates among people without financial means remain to be low despit...
Posted in Cancer News Today, Cancer Research0 Comments
22 September 2011
Niiki Pharma Inc. announced interim results from the ongoing Phase I clinical trial of its lead product, NKP-1339. NKP-1339 is a first-in-class transferrin targeted small molecule that down-regulates GRP78, a key regulator of mis-folded protein process...
Posted in Cancer News Today, Cancer Research0 Comments
22 September 2011
A new and better understanding of blood vessel growth and vascular development (angiogenesis) in cancer has been made possible by research carried out by a team of scientists from Moffitt Cancer Center, the University of Florida, Harvard University, Ya...
Posted in Cancer News Today, Cancer Research0 Comments
22 September 2011
The Swedish Neuroscience Institute today announced that the Ivy Brain Tumor Center has launched two separate clinical trials for treating brain cancer. The first trial (IND No. 10206, Protocol No. 020221, Study Agent: DCVax Brain Autologous Dendritic c...
Posted in Cancer News Today, Cancer Research0 Comments
22 September 2011
According to new Dutch research featured in the September issue of The Journal of Nuclear Medicine, a peptide receptor radiolabeled therapy (PRRT), [177Lu-DOTA0,Tyr3]Octreotate (177Lu-octreotate), is effective not only in decreasing tumor size but also...
Posted in Cancer News Today, Cancer Research0 Comments
& Receive our FREE *Critical* Updates!
Fight Cancer on Twitter
